Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulation Disorder Neonatal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03855696
What this trial is testing

Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia Patients

Who this might be right for
Hemophilia
Green Cross Corporation 41
Not applicableUnknownNCT05015244
What this trial is testing

Impact of Von Willebrand Factor-platelet Aggregates in Patients With Type 2B Disease

Who this might be right for
Von Willebrand Disease, Type 2B
University Hospital, Caen 5
Not applicableStudy completedNCT02300519
What this trial is testing

Thrombin Generation Numerical Models Validation in Haemophilic Case

Who this might be right for
Haemophilia BHaemophilia A
Centre Hospitalier Universitaire de Saint Etienne 40
Large-scale testing (Phase 3)Study completedNCT00618098
What this trial is testing

Study of Octaplex (Human Prothrombin Complex Concentrate) and Fresh Frozen Plasma in Patients Under Vitamin K Therapy Antagonist Needing Urgent Surgery or Invasive Procedures

Who this might be right for
Reversal of Anticoagulant Treatment
Octapharma 200
Not applicableStudy completedNCT05895032
What this trial is testing

Trial of an Exercise Intervention for Children With Haemophilia

Who this might be right for
HemophiliaChild, OnlyMusculoskeletal Diseases or Conditions
East Kent Hospitals University NHS Foundation Trust 132
Not applicableStudy completedNCT02279199
What this trial is testing

Motor Proficiency of People With Bleeding Disorders Using the BOT-2 (TM)

Who this might be right for
Hemophilia
Oregon Health and Science University 45
Early research (Phase 1)Study completedNCT00114257
What this trial is testing

Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more
National Cancer Institute (NCI) 36
Large-scale testing (Phase 3)Study completedNCT00168077
What this trial is testing

Prothrombin Complex Concentrate for Anticoagulant Reversal

Who this might be right for
Acquired Coagulation Factor Deficiency
CSL Behring 40
Not applicableStudy completedNCT01234545
What this trial is testing

Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 35
Large-scale testing (Phase 3)Looking for participantsNCT05568719
What this trial is testing

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

Who this might be right for
Hemophilia AHemophilia B
Pfizer 173
Not applicableEnrolling By InvitationNCT06285071
What this trial is testing

Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors

Who this might be right for
Haemophilia AHaemophilia B
Novo Nordisk A/S 23
Not applicableLooking for participantsNCT07682519
What this trial is testing

Multimodal Telerehabilitation Versus Face-to-Face Care for Adults With Hemophilia and Chronic Pain

Who this might be right for
HemophiliaChronic Pain
University of Chile 24
Large-scale testing (Phase 3)Study completedNCT01662531
What this trial is testing

A Safety, Efficacy and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Children With Hemophilia B

Who this might be right for
Hemophilia B
CSL Behring 27
Testing effectiveness (Phase 2)WithdrawnNCT01101412
What this trial is testing

Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies

Who this might be right for
Chronic Myeloproliferative DisordersInfectionLeukemia+6 more
M.D. Anderson Cancer Center
Not applicableStudy completedNCT04334057
What this trial is testing

Post-Marketing Surveillance (Use-results Surveillance) With Esperoct®

Who this might be right for
Haemophilia A
Novo Nordisk A/S 23
Not applicableStudy completedNCT03560570
What this trial is testing

Study of Hemostasis in Patients With Congenital Disorder of Glycosylation

Who this might be right for
Congenital Disorders of Glycosylation
Assistance Publique - Hôpitaux de Paris 57
Not applicableUnknownNCT02781766
What this trial is testing

TGA (Thrombin Generation Assay) and Prophylaxis in Haemophilia

Who this might be right for
Haemophilia A
Hospices Civils de Lyon 50
Not applicableUnknownNCT06565481
What this trial is testing

Measurement Properties in People with Hemophilia

Who this might be right for
Hemophilia aHemophilia BMusculoskeletal Complication+1 more
University of Zurich 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT06738901
What this trial is testing

An Open-label Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of SKP-0141 for the Treatment and Prophylaxis in Severe Hemophilia a Patients

Who this might be right for
Hemophilia A, Severe
SK Plasma Co., Ltd. 55
Testing effectiveness (Phase 2)Study completedNCT06010953
What this trial is testing

SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment

Who this might be right for
MaleHemophilia A With InhibitorHemophilia B With Inhibitor+1 more
Hangzhou Gensciences Biopharmaceutical Co., Ltd. 24
Next Page